Skip to content
Research Article Open access CC BY 4.0

Treatment Outcomes of Retinoblastoma in Children Less than 6 Months of Age

Hussain Ahmad Khaqan, Hafiz Ateeq ur Rehman, Laraib Hassan, Aamna Jabran, Ahmad Fauzan, Nabeel Akram, Asad Mahmood Khan

Journal of Advances in Medical and Pharmaceutical Sciences · pp. 24–28 · Published 4 Mar 2024

10.9734/jamps/2024/v26i4680

Abstract

Objective: To assess the results of children who have been diagnosed with retinoblastoma in less than 6 months of age in terms of globe saving and the need for chemoreduction (CRD). Materials and Methods: This is a retrospective study from 2018 to 2021 that includes 8 eyes of 4 infants. Of the 4 patients, 01 (25%) patient was male and 03 (75%) were females. All patients had bilateral disease with no positive family history. The 4 patients were classified according to the International Classification System for Retinoblastoma. Group A disease was diagnosed in 1 (12.5%) eye, Group B in 2 (25%), Group C in 1 (12.5%), Group D in 1 (12.5%), and Group E in 3 (37.5%) eyes. A performa was made that included; patient’ name, date of birth, date of diagnosis, gender, laterality of retinoblastoma, family history, systemic chemotherapy agents used with the number of cycles and details of local therapy, complications, development of secondary malignancies and deaths. Primary outcome measures were the need for CRD and globe salvage. Results: Three (75%) of the four infants having retinoblastoma in less than six months needed CRD to save their globes. 62.5 percent (5/8) of eyes had their globes saved, whereas three eyes (37.5 percent) were enucleated due to Group E illness. There were no CRD-related hospitalization and all patients survived. Conclusion: Collectively the targeted modalities and reduced-dose CRD, children having retinoblastoma with less than six months have more chances of globe saving comparable to those of older age groups. The saving of globe of two-thirds of the infants required CRD. A diagnosis of Group D or E in at least one eye initially or both eyes later on, increased the risk of requiring CRD (p 0.0001 and p 0.016, respectively).

Retinoblastoma 6 months of age globe salvage chemoreduction

References (15)

  1. 1 Intraocular Retinoblastoma: the Case for a New Group Classification [DOI]
  2. 2 Chemoreduction in the Initial Management of Intraocular Retinoblastoma [DOI]
  3. 3 Second nonocular tumors in survivors of bilateral retinoblastoma [DOI]
  4. 4 Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy [DOI]
  5. 5 Carboplatin-Associated Ototoxicity in Children With Retinoblastoma [DOI]
  6. 6 Long‐term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low‐dose IMRT salvage [DOI]
  7. 7 Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma [DOI]
  8. 8 Retinoblastoma Incidence Patterns in the US Surveillance, Epidemiology, and End Results Program [DOI]
  9. 9 Vincristine Neurotoxicity [DOI]
  10. 10 Retinoblastoma treated with primary chemotherapy alone: the significance of tumour size, location, and age [DOI]
  11. 11 Retinoblastoma in the first year of life [DOI]
  12. 12 Low-Dose Chemoreduction for Infants Diagnosed with Retinoblastoma before 6 Months of Age [DOI]
  13. 13 Retinoblastoma Treated in Infants in the First Six Months of Life [DOI]
  14. 14 Outcome Following Initial External Beam Radiotherapy in Patients with Reese-Ellsworth Group Vb Retinoblastoma
  15. 15 Neonatal Retinoblastoma in the First Month of Life [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

18

Page views

0

PDF downloads

2

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.